Xiaofeng Ma , Zhonglei Xu , Xinrui Wang , Shiying Sun , Junhui Zhang , Ruxian Tang , Lin Ling , Bing Wei , Liangchang Hu , Enlin Wang
{"title":"Aberrant WDR5 promotes the progression of cervical cancer through the YAP1- CTGF pathway","authors":"Xiaofeng Ma , Zhonglei Xu , Xinrui Wang , Shiying Sun , Junhui Zhang , Ruxian Tang , Lin Ling , Bing Wei , Liangchang Hu , Enlin Wang","doi":"10.1016/j.lfs.2025.123712","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>WDR5 plays a pivotal role in promoting cancer progression across various malignancies. However, its involvement in cervical cancer remains poorly understood. This study aims to elucidate the mechanisms by which WDR5 drives cervical cancer progression.</div></div><div><h3>Materials and methods</h3><div>Cervical cancer tissues were analyzed to assess WDR5 regulation. <em>In vitro</em> assays evaluated the effects of WDR5 loss-of-function on cell proliferation, migration, and invasion. Mechanistic studies investigated the interaction between WDR5 and YAP1, and the subsequent modulation of CTGF gene expression <em>via</em> histone 3 lysine 4 trimethylation. Xenograft tumor models were utilized to examine the <em>in vivo</em> role of WDR5 in cervical cancer progression.</div></div><div><h3>Key findings</h3><div>WDR5 is significantly upregulated in cervical cancer tissues and correlates with poor prognosis. Loss of WDR5 function markedly suppresses cervical cancer cell proliferation, migration, and invasion <em>in vitro</em>. WDR5 interacts with YAP1, enhancing CTGF expression through histone methylation. <em>In vivo</em>, the oncogenic function of WDR5 is contingent upon the YAP1-CTGF signaling axis.</div></div><div><h3>Significance</h3><div>This study identifies the WDR5/YAP1/CTGF pathway as a key mechanism in cervical cancer progression, suggesting that targeting this axis may provide a promising therapeutic approach.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"376 ","pages":"Article 123712"},"PeriodicalIF":5.2000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320525003479","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
WDR5 plays a pivotal role in promoting cancer progression across various malignancies. However, its involvement in cervical cancer remains poorly understood. This study aims to elucidate the mechanisms by which WDR5 drives cervical cancer progression.
Materials and methods
Cervical cancer tissues were analyzed to assess WDR5 regulation. In vitro assays evaluated the effects of WDR5 loss-of-function on cell proliferation, migration, and invasion. Mechanistic studies investigated the interaction between WDR5 and YAP1, and the subsequent modulation of CTGF gene expression via histone 3 lysine 4 trimethylation. Xenograft tumor models were utilized to examine the in vivo role of WDR5 in cervical cancer progression.
Key findings
WDR5 is significantly upregulated in cervical cancer tissues and correlates with poor prognosis. Loss of WDR5 function markedly suppresses cervical cancer cell proliferation, migration, and invasion in vitro. WDR5 interacts with YAP1, enhancing CTGF expression through histone methylation. In vivo, the oncogenic function of WDR5 is contingent upon the YAP1-CTGF signaling axis.
Significance
This study identifies the WDR5/YAP1/CTGF pathway as a key mechanism in cervical cancer progression, suggesting that targeting this axis may provide a promising therapeutic approach.
期刊介绍:
Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.